| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| D B Marin, B Breuer, M L Marin, J Silverman, J Schmeidler, D Greenberg, S Flynn, M Mare, M Lantz, L Libow, R Neufeld, L Altstiel, K L Davis, R C Moh. The relationship between apolipoprotein E, dementia, and vascular illness. Atherosclerosis. vol 140. issue 1. 1998-11-24. PMID:9733229. |
the purpose of this study was to concurrently assess the relationship of apolipoprotein e (apoe) with both dementias and vascular illnesses in the very old. |
1998-11-24 |
2023-08-12 |
human |
| D B Marin, B Breuer, M L Marin, J Silverman, J Schmeidler, D Greenberg, S Flynn, M Mare, M Lantz, L Libow, R Neufeld, L Altstiel, K L Davis, R C Moh. The relationship between apolipoprotein E, dementia, and vascular illness. Atherosclerosis. vol 140. issue 1. 1998-11-24. PMID:9733229. |
all subjects were studied for the relationship of apoe with atherosclerotic heart disease, hypertension, or stroke without concomitant dementia. |
1998-11-24 |
2023-08-12 |
human |
| D B Marin, B Breuer, M L Marin, J Silverman, J Schmeidler, D Greenberg, S Flynn, M Mare, M Lantz, L Libow, R Neufeld, L Altstiel, K L Davis, R C Moh. The relationship between apolipoprotein E, dementia, and vascular illness. Atherosclerosis. vol 140. issue 1. 1998-11-24. PMID:9733229. |
four hundred fifty individuals met criteria for inclusion into one of the following groups: alzheimer's disease (n = 318), vascular dementia (n = 49), or not demented controls (n = 83) and were investigated for the relationship between apoe and these diagnostic categories. |
1998-11-24 |
2023-08-12 |
human |
| D B Marin, B Breuer, M L Marin, J Silverman, J Schmeidler, D Greenberg, S Flynn, M Mare, M Lantz, L Libow, R Neufeld, L Altstiel, K L Davis, R C Moh. The relationship between apolipoprotein E, dementia, and vascular illness. Atherosclerosis. vol 140. issue 1. 1998-11-24. PMID:9733229. |
apoe epsilon4 was not associated with atherosclerotic heart disease, hypertension, or stroke without concomitant dementia. |
1998-11-24 |
2023-08-12 |
human |
| D B Marin, B Breuer, M L Marin, J Silverman, J Schmeidler, D Greenberg, S Flynn, M Mare, M Lantz, L Libow, R Neufeld, L Altstiel, K L Davis, R C Moh. The relationship between apolipoprotein E, dementia, and vascular illness. Atherosclerosis. vol 140. issue 1. 1998-11-24. PMID:9733229. |
in contrast, the apoe epsilon4 allele was more common in patients with alzheimer's disease (22%) and vascular dementia (26%) than in not demented controls (7%). |
1998-11-24 |
2023-08-12 |
human |
| D B Marin, B Breuer, M L Marin, J Silverman, J Schmeidler, D Greenberg, S Flynn, M Mare, M Lantz, L Libow, R Neufeld, L Altstiel, K L Davis, R C Moh. The relationship between apolipoprotein E, dementia, and vascular illness. Atherosclerosis. vol 140. issue 1. 1998-11-24. PMID:9733229. |
apoe epsilon4 is associated with dementias in the very old, whereas its relationship with either peripheral or central nervous system vascular disease without dementia is not as robust. |
1998-11-24 |
2023-08-12 |
human |
| E H Corder, L Lannfelt, N Bogdanovic, L Fratiglioni, H Mor. The role of APOE polymorphisms in late-onset dementias. Cellular and molecular life sciences : CMLS. vol 54. issue 9. 1998-11-10. PMID:9791536. |
the role of apoe polymorphisms in late-onset dementias. |
1998-11-10 |
2023-08-12 |
mouse |
| D M Mann, S M Brown, F Owen, M Baba, T Iwatsub. Amyloid beta protein (A beta) deposition in dementia with Lewy bodies: predominance of A beta 42(43) and paucity of A beta 40 compared with sporadic Alzheimer's disease. Neuropathology and applied neurobiology. vol 24. issue 3. 1998-11-06. PMID:9717183. |
amyloid beta protein (a-beta) deposition was investigated by quantitative immunohistochemistry in 13 cases of dementia with lewy bodies (dlb) and compared with that in a series of age, gender and apoe genotype matched cases of alzheimer's disease (ad). |
1998-11-06 |
2023-08-12 |
Not clear |
| E H Corder, K Robertson, L Lannfelt, N Bogdanovic, G Eggertsen, J Wilkins, C Hal. HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nature medicine. vol 4. issue 10. 1998-10-28. PMID:9771753. |
hiv-infected subjects with the e4 allele for apoe have excess dementia and peripheral neuropathy. |
1998-10-28 |
2023-08-12 |
human |
| Y Ji, K Urakami, Y Adachi, M Maeda, K Isoe, K Nakashim. Apolipoprotein E polymorphism in patients with Alzheimer's disease, vascular dementia and ischemic cerebrovascular disease. Dementia and geriatric cognitive disorders. vol 9. issue 5. 1998-10-08. PMID:9701675. |
apolipoprotein e sigma4 allele (apoe sigma4) is associated with alzheimer's disease (ad) in familial and sporadic cases, but the associations of apoe sigma4 allele and vascular dementia (vd) and/or ischemic cerebrovascular disease (icvd) are still controversial. |
1998-10-08 |
2023-08-12 |
human |
| Y Ji, K Urakami, Y Adachi, M Maeda, K Isoe, K Nakashim. Apolipoprotein E polymorphism in patients with Alzheimer's disease, vascular dementia and ischemic cerebrovascular disease. Dementia and geriatric cognitive disorders. vol 9. issue 5. 1998-10-08. PMID:9701675. |
these findings suggest that the genotype of apoe sigma4 is associated with not only ad but also vd and icvd, and that apoe sigma4 plays an important role in the development of dementia and icvd. |
1998-10-08 |
2023-08-12 |
human |
| Y Forsell, H Basun, E H Corder, L Lannfelt, B Winbla. Psychotic symptoms and apolipoprotein E genotypes in an elderly population. Biological psychiatry. vol 44. issue 2. 1998-09-08. PMID:9646896. |
genetic variation in the apolipoprotein e (apoe) gene is reported to be associated with variation in the risk of alzheimer's dementia. |
1998-09-08 |
2023-08-12 |
Not clear |
| O L Lopez, S Lopez-Pousa, M I Kamboh, R Adroer, R Oliva, M Lozano-Gallego, J T Becker, S T DeKosk. Apolipoprotein E polymorphism in Alzheimer's disease: a comparative study of two research populations from Spain and the United States. European neurology. vol 39. issue 4. 1998-08-27. PMID:9635474. |
we examined the distribution of the apolipoprotein e (apoe) polymorphism in two caucasian populations of alzheimer's disease (ad) patients referred to dementia clinics; one in gerona, spain (66 ad patients, 49 controls), and the other in pittsburgh, pa., usa (209 ad patients, 58 controls). |
1998-08-27 |
2023-08-12 |
Not clear |
| Y Sekijima, S Ikeda, T Tokuda, S Satoh, H Hidaka, E Hidaka, M Ishikawa, N Yanagisaw. Prevalence of dementia of Alzheimer type and apolipoprotein E phenotypes in aged patients with Down's syndrome. European neurology. vol 39. issue 4. 1998-08-27. PMID:9635475. |
we investigated the exact prevalence of dementia of alzheimer type (dat) and apolipoprotein e (apoe) phenotypes in 106 japanese down's syndrome (ds) patients. |
1998-08-27 |
2023-08-12 |
Not clear |
| J Bratosiewicz-Zapart, I Kłoszewska, T Sobów, P P Libersk. Distribution of apolipoprotein E4 isoform in Alzheimer's disease in Poland. Archivum immunologiae et therapiae experimentalis. vol 45. issue 2-3. 1998-08-12. PMID:9597090. |
alzheimer's disease (ad) is the most common human progressive dementia linked, in its sporadic form, to a common polymorphism within a gene for apolipoprotein e (apoe) mapped to chromosome 19. |
1998-08-12 |
2023-08-12 |
human |
| A J Slooter, M Cruts, S Kalmijn, A Hofman, M M Breteler, C Van Broeckhoven, C M van Duij. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Archives of neurology. vol 55. issue 7. 1998-08-06. PMID:9678314. |
to provide risk estimates of dementia and alzheimer disease as a function of the apolipoprotein e (apoe) genotypes and to assess the proportion of dementia that is attributable to the apoe genotypes. |
1998-08-06 |
2023-08-12 |
Not clear |
| J Chapman, N Wang, T A Treves, A D Korczyn, N M Bornstei. ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer's dementia. Stroke. vol 29. issue 7. 1998-07-30. PMID:9660395. |
ace, mthfr, factor v leiden, and apoe polymorphisms in patients with vascular and alzheimer's dementia. |
1998-07-30 |
2023-08-12 |
Not clear |
| K Wakabayashi, A Kakita, S Hayashi, K Okuizumi, O Onodera, H Tanaka, A Ishikawa, S Tsuji, H Takahash. Apolipoprotein E epsilon4 allele and progression of cortical Lewy body pathology in Parkinson's disease. Acta neuropathologica. vol 95. issue 5. 1998-07-13. PMID:9600590. |
to elucidate whether the apolipoprotein e epsilon4 allele (apoe4) affects cortical neuropathology in parkinson's disease (pd), we determined apoe genotypes and quantified the densities of cortical lewy bodies (lbs), amyloid plaques and neurofibrillary tangles in 22 autopsy-proven pd cases (12 with dementia; 10 without dementia) that were not accompanied by alzheimer's disease. |
1998-07-13 |
2023-08-12 |
Not clear |
| M M Lalowski, K Czyzewski, A Pfeffer, M Barcikowska, H Kwiecińsk. ApoE polymorphism in Polish patients with Alzheimer's disease. Acta neurobiologiae experimentalis. vol 58. issue 1. 1998-06-08. PMID:9583189. |
apoe genotypes were determined in 30 mild to moderate ad (83%) and mixed dementia (mix, 17%), as well as in 11 nondemented first-degree relatives of ad (ndr), recruited from ad patient registry in warsaw. |
1998-06-08 |
2023-08-12 |
Not clear |
| S Burlinson, A Burns, D Mann, S Pickering-Brown, F Owe. Effect of apolipoprotein E status on clinical features of dementia. International journal of geriatric psychiatry. vol 13. issue 3. 1998-06-03. PMID:9565840. |
the aims of this study were (a) to determine the frequency of apoe genotypes in dementia, (b) to relate e4 allele frequency to clinical symptomatology of dementia and (c) to relate e4 and assess risk factors for different types of dementia. |
1998-06-03 |
2023-08-12 |
Not clear |